×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
EVIDENCE FOR DECISIONS ON HEALTH BENEFITS - ROLE OF HTA · 2020-01-27 · Cost-utility of Trastuzumab expressed as number of GDP per QALY 0.0 5.0 10.0 15.0 20.0 25.0 30.0 35.0 40.0
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form